A Gender divide in Prameha: Women's Natural Resilience

format_list_numberedReferences

1. Textbook of Roga Nidana & Vikriti Vigyana; First Edition;Nagpur; Rashtra Gaurav Publication; 2019.p.204.
2. Vaidhya Jadavji Trikamji Acharya, Sushruta Samhita with Nibandhasangraha commentary, Nidana sthana, Chaukhamba Surbharati prakashan, P -289,826.
3. Vaidhya Laksmipati Sastri, Yogaratnakara with Vidyotini Hindi commentary Uttarardha Prameha Nidanam, Edition 2024, Chaukhambha prakashan, P-79,504.
4. Vaidhya Jadavji Trikamji Acharya, Sushruta Samhita with Nibandhasangraha commentary, Nidana sthana, Chaukhamba Surbharati prakashan, P -289,826.
5. Dr.B. RamaRao, Astanga Hrdaya of Vagbhata, Vol-I, Sarirasthana Chapter I, Edition 2024, Chaukhambha Vishvabharati, P-349, 503
6. Sonne DP., Hemmingsen B. Comment on American Diabetes Association. Standards of Medical care in Diabetes - 2017. Diabetes Care. Diabetes Care.2017;2017;4040
7. Dr.B. RamaRao, Astanga Hrdaya of Vagbhata, Vol-I, Sarirasthana Chapter I, Edition 2024, Chaukhambha Vishvabharati, P-349, 503
8. Howden L, Meyer J. Age & Sex Composition: 2010. 2010 Census briefs. US Census Bureau, Washington, DC, USA (2011).
9. Soules M, Sherman S, Parrott E et al. Executive summary: Stages of Reproductive Aging Worshop (STRAW). Fertil. Steril. 76(5), 876-878 (2001).
10. Sutton-Tyrrell K, Zhao X, Santoro N et al. Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across Nation. Am. J. Epidemiol. 171(11), 1203-1213 (2010).
11. Wartofsky L, Handelsman D. Standarisation of hormonal assays for 21st century. J. Clin. Endocrinol. Metab. 95(12), 5141-5143 (2010).
12. Welt C, McNicholl D, Taylor A, Hall J. Female reproductive aging is marked by decreased secretion of dimericinhibin. J. Clin. Endocrinol. Metab. 84(1), 105-111 (1999).
13. Santoro N, Brown J, Adel T, Skurnick J. Characterisation of reproductive hormonal dynamics in perimenopause. J. Clin. Endocrinol. Metab. 81 (40, 1495-1501 (1996).
14. JuddH,Judd G, Lucas W, Yen S. Endocrine function of the postmenopausal ovary : concentration of androgens & estrogens in ovarian & peripheral vein blood. J. Clin. Endocrinol. Metab. 39, 1020 -1024 (1974).
15. Laughlin G. Barrett connor E, Kritz- Silverstein D, Von Muhlen D. Hysterectomy, oophorectomy, & endogenous sex hormone levels in older women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 85 (2), 645 – 651 (2000).
16. Legro R, Gnatuk C, Kunselman A, Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study, J. Clin. Endocrinol. Metab.90, 3236-3242 (2005).
17. Diamond M, Grainger D, Diamond M, Sherwin R, Defronzo R. Effects of methyltestosterone on insulin secretion & sensitivity in women. J. Clin. Endocrinol. Metab.83(12), 4420--4425 (1998).
18. Ding E, Song Y, Manson J et al. Sex hormone-binding globulin & risk of Type 2 diabetes in women & men. N. Engl.J. Med. 361(12), 1152-1163 (2009).
19. Ding E, Song Y, Malik V, Liu S. Sex differences of endogenous sex hormones and risk of Type 2 diabetes. JAMĀ 295, 1288–1299 (2006).
20. Kalyani R, Franco M, Dobs A, et al. The association of endogenous sex hormones, adiposity, ad insulin resistance with incident diabetes in postmenopausal women. J. Clin. Endocrinol. Metab. 94 (11), 4127-4135 (2009).
21. Edelstein S, Knowler W, Bain R, et al. Predictors of progression of impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46(4), 701–710 (1997).
22. Kravitz H, Zhao X, Bromberger J, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep 31(7), 979–990 (2008).
23. Stumvoll M, Goldstein B, van Haeften T. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333–1346 (2005).
24. Sowers M, Zheng H, Kravitz H, et al. Sex steroid hormone profiles are related to sleep measures from polysomnography and the Pittsburgh Sleep Quality Index. Sleep 31(10), 1339–1349 (2008).
25. Avas N, White D, Al-Delaimy W, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26(2), 380–384 (2003).
26. Chaput J, Depres J, Bouchard C, Astrup A, Tremblay A. Sleep duration as a risk factor for the development of Type 2 diabetes or impaired glucose tolerance: analysis of the Quebec Family Study. Sleep Med. 10(8), 919–924 (2009).
27. Chaput J, Depres J, Bouchard C, Tremblay A. Association of sleep duration with Type 2 diabetes and impaired glucose tolerance. Diabetologia 50(11), 2298–2304 (2007).
28. Yaggi H, Araujo A, Mckinlay J. Sleep duration as a risk factor for the development of Type 2 diabetes. Diabetes Care 29(3), 657–661 (2006).
29. Reaven G, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathetic system. N. Engl. J. Med. 334, 374–381 (1996).
30. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354, 1435–1439 (1999).
31. Santoleri, D. Titchenell, P.M. Resolving the paradox of hepatic insulin resistance Cell MolGastroenterolHepatol. 2019; 7:447-456
32. Galmés-Pascual, B.M.· Martínez-Cignoni, M.R. Morán-Costoya, A. ... 17β-Estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistance. Free RadicBiol Med. 2020; 150:148-160
33. Schwenk, R.W. Angin, Y. · Steinbusch, L.K. Overexpression of vesicle-associated membrane protein (VAMP) 3, but not VAMP2, protects glucose transporter (GLUT) 4 protein translocation in an in vitro model of cardiac insulin resistance. J Biol Chem. 2012; 287:37530-37539.
34. Janssen, I. Powell, L.H.. Crawford, S. ...Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation Arch Intern Med. 2008; 168:1568-1575.
35. Oya, J. Nakagami, T. · Yamamoto, Y. ...Effects of age on insulin resistance and secretion in subjects without diabetes Intern Med. 2014; 53:941-947.
36. Pu, D. Tan, R. · Yu, Q. ...Metabolic syndrome in menopause and associated factors: a meta-analysis Climacteric. 2017; 20:583-591.
37. Christakis, M.K. · Hasan, H. · De Souza, L.R. ... The effect of menopause on metabolic syndrome: cross-sectional results from the Canadian Longitudinal Study on Aging Menopause. 2020; 27:999-1009.
38. Kim, H.M. · Park, J. · Ryu, S.Y. ...The effect of menopause on the metabolic syndrome among Korean women: the Korean National Health and Nutrition Examination Survey, 2001 Diabetes Care. 2007; 30:701-706
39. Park, Y.-W. · Zhu, S. · Palaniappan, L. ... The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 Arch Intern Med. 2003; 163:427-436.
40. Monteiro, R. · Teixeira, D. · Calhau, C.Estrogen signaling in metabolic inflammation Mediators Inflamm. 2014; 2014:615917.
41. de Rooij, S.R. Nijpels, G. Nilsson, P.M. ... Relationship Between Insulin Sensitivity and Cardiovascular Disease (RISC) Investigators Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease (RISC) population: associations with insulin resistance and cardiometabolic risk profile Diabetes Care. 2009; 32:1295-1301.
42. Abildgaard, J. · Tingstedt, J. · Zhao, Y. ...Increased systemic inflammation and altered distribution of T-cell subsets in postmenopausal women PLoS One. 2020; 15:e0235174.
43. Abu-Taha, M. · Rius, C. · Hermenegildo, C. ... Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan J Immunol. 2009; 183:1393-1402
44. Cushman, M. Legault, C. Barrett-Connor, E. ...Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study Circulation. 1999; 100:717-722.
45. Nandi, A. Kitamura, Y. · Kahn, C.R. ...Mouse models of insulin resistance Physiol Rev. 2004; 84:623-647.
46. De Paoli, M. · Werstuck, G.H.Role of estrogen in type 1 and type 2 diabetes mellitus: a review of clinical and preclinical data Can J Diabetes. 2020; 44:448-452.
47. Santos, R.S. · Batista, T.M. · Camargo, R.L. ...Lacking of estradiol reduces insulin exocytosis from pancreatic β-cells and increases hepatic insulin degradation Steroids. 2016; 114:16-24.
48. Ye, R. · Gordillo, R. · Shao, M. ...Intracellular lipid metabolism impairs β cell compensation during diet-induced obesity J Clin Invest. 2018; 128:1178-1189.
49. van Raalte, D.H. · Diamant, M. Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? Diabetes Res ClinPract. 2011; 93 Suppl 1:S37-S46.
50. van Raalte, D.H. · Diamant, M. Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? Diabetes Res ClinPract. 2011; 93 Suppl 1:S37-S46.
51. Vogel, H. Mirhashemi, F. · Liehl, B. ... Estrogen deficiency aggravates insulin resistance and induces β-cell loss and diabetes in female New Zealand obese mice HormMetab Res. 2013; 45:430-435
52. Adeyanju, O.A. · Soetan, O.A. · Soladoye, A.O. ... Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats Can J PhysiolPharmacol. 2018; 96:577-586.
53. O-Sullivan, I. · Zhang, W. · Wasserman, D.H. ... FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization Nat Commun. 2015; 6:7079.
54. Matsuzaki, H. · Daitoku, H. · Hatta, M. ... Insulin-induced phosphorylation of FKHR (Foxol) targets to proteasomal degradation PNAS. 2003; 100:11285-11290.
55. Yan, H. Yang, W. · Zhou, F. ... Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor Foxo1 Diabetes. 2019; 68:291-304.
56. Gao, H. · Fält, S. · Sandelin, A. ... Genome-wide identification of estrogen receptor alpha-binding sites in mouse liver MolEndocrinol. 2008; 22:10-22.
57. Qiu, S. Vazquez, J.T.· Boulger, E. Hepatic estrogen receptor a is critical for regulation of gluconeogenesis and lipid metabolism in males Sci Rep. 2017; 7:166.
58. Zhu, L. Brown, W.C. · Cai, Q. ... Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance Diabetes. 2013; 62:424-434.
59. Galmés-Pascual, B.M.· Martínez-Cignoni, M.R. · Morán-Costoya, A. ... 17β-Estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistance Free RadicBiol Med. 2020; 150:148-160.
60. Camporez, J.P. · Lyu, K. · Goldberg, E.L. ... Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance J Physiol (Lond). 2019; 597:3885-3903.
61. Mittendorfer, B. Insulin resistance: sex matters CurrOpinClinNutrMetab Care. 2005; 8:367-372.
62. Sam, S. Differential effect of subcutaneous abdominal and visceral adipose tissue on cardiometabolic risk HormMolBiolClin Invest. 2018; 33, 20180014.
63. Mittendorfer, B. Insulin resistance: sex matters CurrOpinClinNutrMetab Care. 2005; 8:367-372.
64. Jazet, I.M. · Pijl, H. · Meinders, A.E. Adipose tissue as an endocrine organ: impact on insulin resistance Neth J Med. 2003; 61:194-212.
65. Geer, E.B. · Shen, W. Gender differences in insulin resistance, body composition, and energy balance Gend Med. 2009; 6 Suppl 1:60-75.
66. Macotela, Y. · Boucher, J. · Tran, T.T. ... Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism Diabetes. 2009; 58:803-812.
67. Stubbins, R.E. · Najjar, K. · Holcomb, V.B. ... Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance Diabetes ObesMetab. 2012; 14:58-66.
68. DeFronzo, R.A. · Jacot, E. · Jequier, E. ... The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization Diabetes. 1981; 30:1000-1007
69. Huang, X. · Liu, G. · Guo, J. ... The PI3K/AKT pathway in obesity and type 2 diabetes Int J Biol Sci. 2018; 14:1483-1496.
70. Abdul-Ghani, M.A. · Defronzo, R.A. Pathogenesis of insulin resistance in skeletal muscle J Biomed Biotechnol. 2010; 2010:476279.
71. Hevener, A. · Reichart, D. · Janez, A. ... Female rats do not exhibit free fatty acid-induced insulin resistance Diabetes. 2002; 51:1907.
72. Bonaventura, M.M. Rodriguez, D. Ferreira, M.L. ... Sex differences in insulin resistance in GABAB1 knockout mice Life Sci. 2013; 92:175-182.
73. Bonaventura, M.M. Catalano, P.N. Chamson-Reig, A. ... GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice Am J PhysiolEndocrinolMetab. 2008; 294:E157-E167.
74. Gómez-Pérez, Y. · Capllonch-Amer, G. Gianotti, M. Long-term high-fat-diet feeding induces skeletal muscle mitochondrial biogenesis in rats in a sex-dependent and muscle-type specific manner NutrMetab (Lond). 2012; 9:15.
75. Rattanavichit, Y. Chukijrungroat, N. Saengsirisuwan, V. Sex differences in the metabolic dysfunction and insulin resistance of skeletal muscle glucose transport following high fructose ingestion Am J PhysiolRegulIntegr Comp Physiol. 2016; 311:1200-1212.
76. Rattanavichit, Y. Chukijrungroat, N. Saengsirisuwan, V. Sex differences in the metabolic dysfunction and insulin resistance of skeletal muscle glucose transport following high fructose ingestion Am J PhysiolRegulIntegr Comp Physiol. 2016; 311:1200-1212.
77. Jia, G. · Whaley-Connell, A. · Sowers, J.R. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease Diabetologia. 2018; 61:21-28.
78. Roedebusch, R. · Belenchia, A. · Pulakat, L. Diabetic cardiomyopathy: impact of biological sex on disease development and molecular signatures Front Physiol. 2018; 9:453.
79. Sivasinprasasn, S. · Tanajak, P. · Pongkan, W. ... DPP-4 inhibitor and estrogen share similar efficacy against cardiac ischemic-reperfusion injury in obese-insulin resistant and estrogen-deprived female rats Sci Rep. 2017; 7:44306.
80. Zhang, B. · Zhang, J. · Zhang, C. ... Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor a and its downstream signaling Front Pharmacol. 2018; 9:1227.
81. incent, M.A. · Montagnani, M. · Quon, M.J. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium CurrDiab Rep. 2003; 3:279-288
82. Muniyappa, R. Quon, M.J. Insulin action and insulin resistance in vascular endothelium CurrOpinClinNutrMetab Care. 2007; 10:523-530.
83. Meadows, J.L. Vaughan, D.E. Endothelial biology in the post-menopausal obese woman Maturitas. 2011; 69:120-125.
84. van Sloten, T.T. · Henry, R.M. · Dekker, J.M. ... Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes Hypertension. 2014; 64:1299-1305
85. Benjamin, E.J. · Larson, M.G. · Keyes, M.J. ... Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study Circulation. 2004; 109:613-619.
86. Paradisi, G. · Steinberg, H.O. · Hempfling, A. ... Polycystic ovary syndrome is associated with endothelial dysfunction Circulation. 2001; 103:1410-1415.
87. Dube, R. Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome? Avicenna J Med. 2016; 6:91-102.
88. Paradisi, G. Steinberg, H.O. Hempfling, A. ...Polycystic ovary syndrome is associated with endothelial dysfunction Circulation. 2001; 103:1410-1415
89. Dube, R. Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome? Avicenna J Med. 2016; 6:91-102.
90. Brooks-Asplund, E.M. Shoukas, A.A. · Kim, S.-Y. ... Estrogen has opposing effects on vascular reactivity in obese, insulin-resistant male Zucker rats J Appl Physiol. 2002; 92:2035-2044.
91. Song, D. Yuen, V.G. · Yao, L. ... Chronic estrogen treatment reduces vaso-constrictor responses in insulin resistant rats Can J PhysiolPharmacol. 2006; 84:1139-1143.